Repurposing a drug can bring new treatment options to patients in need – Sharing Progress in Cancer Care

Sharing Progress in Cancer Care posted on LinkedIn:

“Repurposing a drug with a known mode of action to work in a different disease setting can offer a faster and cheaper way to bring new treatment options to patients in need.

Sophie Fessl looks at a proposed revision to the EU’s pharmaceutical regulation that could help unleash that strategy.

Read the full article on Cancerworld.”

Source: Sharing Progress in Cancer Care/LinkedIn

Sophie Fessl is a Science Communication Professional. She is the Head of Communications at Institute of Molecular Biotechnology and Gregor Mendel Institute. She was also a science writer at IST Austria.